Cancer drugs offer new hope for Crohn”s disease and sarcoidosis

cancerA new study offers insight into a new treatment avenue for two painful inflammatory diseases: Crohn”s sisease and sarcoidosis. While the loss of NOD2 increases the risk of developing Crohn”s disease, increased activity of this gene is also thought to exacerbate symptoms. Additionally, activating NOD2 mutations can cause genetic sarcoidosis – an inflammatory disease affecting